Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Baudax Bio, Inc. (BXRX) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Baudax Bio, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1780097.
Total stock buying since 2020: $250,504.
Total stock sales since 2020: $0.
Total stock option exercises since 2020: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 199,200 | $141,564 | 0 | $0 | 0 | $0 |
| 2020 | 46,500 | $108,940 | 0 | $0 | 25,070 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-09 | 8,200 | $4,797 | 0 | $0 | 0 | $0 |
| 2021-08 | 150,000 | $88,400 | 0 | $0 | 0 | $0 |
| 2021-05 | 16,000 | $13,192 | 0 | $0 | 0 | $0 |
| 2021-03 | 25,000 | $35,175 | 0 | $0 | 0 | $0 |
| 2020-03 | 46,500 | $108,940 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 0 | $0 | 25,070 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-09-22 | Henwood Geraldine (President and CEO) | Buy | 8,200 | .58 | 4,797 |
| 2021-08-31 | Churchill Winston J (Director) | Buy | 100,000 | .63 | 62,900 |
| 2021-08-20 | Casten Richard S (Chief Financial Officer) | Buy | 50,000 | .51 | 25,500 |
| 2021-05-11 | Baskies Arnold M (Director) | Buy | 10,000 | .82 | 8,200 |
| 2021-05-07 | Henwood Geraldine (President and CEO) | Buy | 6,000 | .83 | 4,992 |
| 2021-03-15 | Casten Richard S (Chief Financial Officer) | Buy | 25,000 | 1.41 | 35,175 |
| 2020-03-26 | Weisman Wayne (Director) | Buy | 10,000 | 2.29 | 22,900 |
| 2020-03-26 | Altomari Alfred (Director) | Buy | 5,000 | 2.34 | 11,700 |
| 2020-03-26 | Churchill Winston J (Director) | Buy | 31,500 | 2.36 | 74,340 |
| 2020-01-27 | Lake Ryan David (Chief Financial Officer) | Option Ex | 6,000 | .00 | 0 |
| 2020-01-27 | Henwood Geraldine (President and CEO) | Option Ex | 19,070 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of BXRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Baudax Bio, Inc. (symbol BXRX, CIK number 1780097) see the Securities and Exchange Commission (SEC) website.